Cel Sci CVM
NYSE CVM
$1.51 -0.03 (-2.25%)
As of: Oct 21, 2026 · 11:37 AM EDT

Cel Sci (CVM) FCF Margin (2011 - 2023)

Updated

Cel Sci's FCF Margin came in at -17972.71% for fiscal Q3 2017 (quarter ended Jun 30, 2017), down 13798.36 percentage points from -4174.34% a year earlier.

Analysis

Cel Sci (CVM) FCF Margin (2011 - 2023) Analysis & Trends

Over the trailing twelve months to Jun 30, 2017, Cel Sci reported FCF Margin of -6737.19%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.82%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 18.33%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 6.55%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.70%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 44.00%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 2.01%
10 Cel Sci 2.74 Mn -22.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -4,767.06%
Sep 30, 2022 -1,300.66%
Mar 31, 2021 -3,235.40%
Jun 30, 2017 -17,972.71%
Jun 30, 2016 -4,174.34%
Jun 30, 2011 -9,372.29%
API Access

Cel Sci FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=CVM&period=max&api_key=YOUR_API_KEY